These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8695919)

  • 1. [Pharmacology of Catharanthus alkaloids].
    Levêque D; Wihlm J; Jehl F
    Bull Cancer; 1996 Mar; 83(3):176-86. PubMed ID: 8695919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
    Pereira E; Tarasiuk J; Garnier-Suillerot A
    Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of vinca alkaloid analogues.
    Voss ME; Ralph JM; Xie D; Manning DD; Chen X; Frank AJ; Leyhane AJ; Liu L; Stevens JM; Budde C; Surman MD; Friedrich T; Peace D; Scott IL; Wolf M; Johnson R
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1245-9. PubMed ID: 19147348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental in vivo cross-resistance of vinca alkaloid drugs.
    Maral R; Bourut C; Chenu E; Mathe G
    Cancer Chemother Pharmacol; 1981; 5(3):197-9. PubMed ID: 7296754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
    Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
    Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer.
    Zhang Y; Yang SH; Guo XL
    Biomed Pharmacother; 2017 Dec; 96():659-666. PubMed ID: 29035832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine.
    Sertel S; Fu Y; Zu Y; Rebacz B; Konkimalla B; Plinkert PK; Krämer A; Gertsch J; Efferth T
    Biochem Pharmacol; 2011 Mar; 81(6):723-35. PubMed ID: 21219884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From periwinkle to an enduring anticancer drug.
    Faguet G
    Lancet Oncol; 2021 Mar; 22(3):308. PubMed ID: 33662284
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth inhibitory activity of S12363, a novel vinca alkaloid derivative on human melanoma cell lines.
    Tolis C; Photiou A; Camplejohn RS; Retsas S
    Anticancer Res; 1993; 13(1):161-6. PubMed ID: 8476208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catharanthine C16 substituent effects on the biomimetic coupling with vindoline: preparation and evaluation of a key series of vinblastine analogues.
    Tam A; Gotoh H; Robertson WM; Boger DL
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6408-10. PubMed ID: 20932748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riboflavin-mediated photosensitization of Vinca alkaloids distorts drug sensitivity assays.
    Granzow C; Kopun M; Kröber T
    Cancer Res; 1995 Nov; 55(21):4837-43. PubMed ID: 7585517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradation of the antineoplastics vindesine, vincristine, and vinblastine and their toxicity against bacteria in the aquatic environment.
    Al-Ahmad A; Kümmerer K
    Cancer Detect Prev; 2001; 25(1):102-7. PubMed ID: 11270417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical and clinical pharmacology of vinca alkaloids.
    Zhou XJ; Rahmani R
    Drugs; 1992; 44 Suppl 4():1-16; discussion 66-9. PubMed ID: 1283846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Biological Activity of the Novel Vinca Alkaloids 4-chlorochablastine and 4-chlorochacristine.
    Montag G; Stopper H; Ngo QA; Hintzsche H
    Curr Cancer Drug Targets; 2019; 19(3):222-230. PubMed ID: 29714145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.
    Poppitt DG; McGown AT; Fox BW
    Cancer Chemother Pharmacol; 1984; 13(1):43-6. PubMed ID: 6733841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro.
    Jordan MA; Himes RH; Wilson L
    Cancer Res; 1985 Jun; 45(6):2741-7. PubMed ID: 3986806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antagonism between cisplatin and vinca alkaloids.
    Lee K; Tanaka M; Kanamaru H; Hashimura T; Yamamoto I; Konishi J; Kuze F
    Br J Cancer; 1989 Jan; 59(1):36-41. PubMed ID: 2757923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel aspects of natural and modified vinca alkaloids.
    Duflos A; Kruczynski A; Barret JM
    Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):55-70. PubMed ID: 12678751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.
    Rivera-Fillat MP; Pallarés-Trujillo J; Domènech C; Grau-Oliete MR
    Br J Pharmacol; 1988 Apr; 93(4):902-8. PubMed ID: 3390658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of fluorinated catharanthine analogues and investigation of their biomimetic coupling with vindoline.
    Giovanelli E; Moisan L; Comesse S; Leroux S; Rousseau B; Hellier P; Nicolas M; Doris E
    Org Biomol Chem; 2013 Sep; 11(35):5885-91. PubMed ID: 23903701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.